Skip to main content Skip to main navigation menu Skip to site footer

Vitamin D Receptor (VDR) Apa1 gene polymorphism increasing the risk of breast cancer women in Bali, Indonesia

  • I Putu Gede Fajar Mahayasa ,
  • I Ketut Widiana ,
  • Putu Anda Tusta Adiputra ,
  • I Wayan Sudarsa ,


Abstract

Background: Breast cancer is the most common cancer diagnosed in women. It basically caused by a progressive accumulation of genetic disorders. Vitamin D and its receptor (VDR) have been shown to have an effect on the carcinogenesis of breast cancer. Several studies have shown VDR Apa1 polymorphisms became the most prevalent polymorphism of other polymorphism variants of breast cancer. There are still lack of studies that review the relationship of VDR gene polymorphisms, especially Apa1 on breast cancer risk among Balinese woman.

Method: This study was a case-control design- analytic study to see the relationship between Vitamin D receptor Apa1 gene polymorphism and breast cancer risk in Balinese women. There were 42 venous blood samples from breast cancer women and healthy women in Bali. This study was carried out at the Faculty of Medicine Integrated Biomedical Laboratory. DNA isolation was done for sequencing to determine the sequence of gene bases. Then the data were analyzed using SPSS 16.

Results: Univariate analysis showed the characteristics of the subject and research variables. Bivariate analysis showed that the presence of VDR Apa1 polymorphism in Balinese women increased the risk of breast cancer by 5,846-fold higher compared to women without polymorphism (CI95%:1.065- 32.082; P = 0.03). Multivariate analysis confirmed that the VDR Apa1 polymorphism independently influence and increase the risk of breast cancer without being influenced by other variables (95% CI: 1.065-32.082; P = 0.042).

Conclusion: In this study has shown VDR Apa1 polymorphism significantly associated and increased the risk of breast cancer in women in Bali.

Keywords: Breast cancer Polymorphism VDR (Vitamin D Receptors) Apa1 gene

References

  1. GLOBOCAN. Cancer Fact Sheets: Breast Cancer Estimated Incidence, Mortality, And Prevalnce Worlwide In 2012. GLOBOCAN (IARC). Available from: globocan.iarc.fr. [11 April 2018].
  2. Kementerian Kesehatan Republik Indonesia. Panduan Penatalaksanaan Kanker Payudara. Komite Penanggulangan Kanker Nasional. Kementrian Kesehatan Indonesia. 2016.
  3. Stewart, B. W. K. P., & Wild, C. P. World cancer report 2014. Health. 2017.
  4. Garland, C. F., Garland, F. C., Gorham, E. D., Lipkin, M., Newmark, H., Mohr, S. B., & Holick, M. F. The role of vitamin D in cancer prevention. American journal of public health, 2006. 96(2), 252-261.
  5. Tokitan, A., Matsumoto, H., Morrison, N., Tawa, T., Miura, Y., Fukamauchi, K., Mitsuhashi, N., Irimoto, M., Yamamori, S., Miura, M., Watanabe, T., Kuwabara, Y., Yabuta, K. and Eisman, J. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. Journal of Bone and Mineral Research, 2009;11(7), pp.1003-1009.
  6. Zhou, H., Xu, C. and Gu, M. Vitamin D receptor (VDR) gene polymorphisms and Graves’ disease: a meta-analysis. Clinical Endocrinology, 2009;70(6), pp.938-945.
  7. Zmuda, J., Cauley, J. and Ferrell, R. Molecular Epidemiology of Vitamin D Receptor Gene Variants. Epidemiologic Reviews, 2000;22(2), pp.203-217.
  8. Lopes, N., Sousa, B., Martins, D., Gomes, M., Vieira, D., Veronese, L., Milanezi, F., Paredes, J., Costa, J. and Schmitt, F. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions. BMC Cancer, 2010;10(1).
  9. Arai, H., Miyamoto, K., Yoshida, M., Yamamoto, H., Taketani, Y., Morita, K., Kubota, M., Yoshida, S., Ikeda, M., Watabe, F., Kanemasa, Y. and Takeda, E. The Polymorphism in the Caudal-Related Homeodomain Protein Cdx-2 Binding Element in the Human Vitamin D Receptor Gene. Journal of Bone and Mineral Research, 2001;16(7), 1256-1264.
  10. Faraco, J., Morrison, N., Baker, A., Shine, J. and Frossard, P. Apa1 dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Research, 17(5), pp.2150-2150.
  11. Gong, Z. The PPAR Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas. Carcinogenesis, 1989;26(3), pp.579-585
  12. Gross, C., Eccleshall, T., Malloy, P., Villa, M., Marcus, R. and Feldman, D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal mexican-American women. Journal of Bone and Mineral Research, 2010;11(12), pp.1850-1855.
  13. Ingles, S., Ross, R., Yu, M., Haile, R., Irvine, R., La Pera, G. and Coetzee, G. Association of Prostate Cancer Risk with Genetic Polymorphisms in Vitamin D Receptor and Androgen Receptor. JNCI Journal of the National Cancer Institute, 1997;89(2), pp.166-170.
  14. Morrison, N., Qi, J., Tokita, A., Kelly, P., Crofts, L., Nguyen, T., Sambrook, P. and Eisman, J. Prediction of bone density from vitamin D receptor alleles. Nature, 1994;367(6460), pp.284-287.
  15. Morrison, N., Yeoman, R., Kelly, P. and Eisman, J. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proceedings of the National Academy of Sciences, 1992;89(15), pp.6665-6669.
  16. Rashid, M., Muzaffar, M., Khan, F., Kabisch, M., Muhammad, N., Faiz, S., Loya, A. and Hamann, U. Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study. PLOS ONE, 2015;10(10), p.e0141562.
  17. El-Shorbagy HM, Mahmoud NH, Sabet S. Association of vitamin D receptor gene polymorphisms with breast cancer risk in an Egyptian population. Tumor Biology, 2017;1-9.
  18. Guo, B., Jiang, X., Hu, X., Li, F., & Chen, X. Association between vitamin D receptor gene polymorphisms and breast cancer in a Chinese population. International Journal of Clinical and Experimental Medicine, 2015;8(5), 8020–8024.
  19. Dalessandri, K., Miike, R., Wiencke, J., Farren, G., Pugh, T., Manjeshwar, S., DeFreese, D. and Jupe, E. Vitamin D Receptor Polymorphisms and Breast Cancer Risk in a High-Incidence Population: A Pilot Study. Journal of the American College of Surgeons, 2012;215(5), pp.652-657.
  20. Sikandar, B., Qureshi, M. A., Avesi, L., Sheraz, N., & Mirza, T. Histopathological spectrum of breast diseases in a multi-ethnic population of Karachi, Pakistan. Rawal Medical Journal. 2015:40(1), 52-58.
  21. McCullough, M. L., Bostick, R. M., & Mayo, T. L. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annual review of nutrition. 2009:29, 111-132
  22. Rai, V., Abdo, J. O. E., Agrawal, S., & Agrawal, D. K. Vitamin D receptor polymorphism and cancer: an update. Anticancer research. 2017:37(8), 3991-4003.
  23. Uitterlinden, A. G., Fang, Y., van Meurs, J. B., Pols, H. A., & van Leeuwen, J. P. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004, 338(2), 143-156.
  24. Raimondi, S., Johansson, H., Maisonneuve, P., & Gandini, S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009:30(7), 1170-1180.
  25. Serrano, D., Gnagnarella, P., Raimondi, S., & Gandini, S. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. European Journal of Cancer Prevention. 2016:25(1), 85.
  26. Lee Y H. Song G G. Vitamin D receptor FokI, BsmI, Apa1, and TaqI polymorphisms and the susceptibility to breast cancer: a meta-analysis. Neoplasma. 2014:61, 5, 2014
  27. Iqbal M N, Khan T A. Association between Vitamin D receptor (Cdx2, Fok1, Bsm1, Apa1, Bgl1, Taq1, and Poly (A)) gene polymorphism and breast cancer: A systematic review and meta-analysis. Tumor Biology. October 2017: 1–9.

How to Cite

Mahayasa, I. P. G. F., Widiana, I. K., Adiputra, P. A. T., & Sudarsa, I. W. (2021). Vitamin D Receptor (VDR) Apa1 gene polymorphism increasing the risk of breast cancer women in Bali, Indonesia. Bali Medical Journal, 10(1), 30–34. https://doi.org/10.15562/bmj.v10i1.2113
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
14

Share

Search Panel

I Putu Gede Fajar Mahayasa
Google Scholar
Pubmed
BMJ Journal

I Ketut Widiana
Google Scholar
Pubmed
BMJ Journal

Putu Anda Tusta Adiputra
Google Scholar
Pubmed
BMJ Journal

I Wayan Sudarsa
Google Scholar
Pubmed
BMJ Journal